Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Patient Safety Importance in 2026: How GMP Compliance and Quality Risk Management Protect Patients

Explore how GMP compliance, quality risk management, CAPA, data integrity, and contamination control connect manufacturing decisions to patient protection. This article explains what inspectors look for, which evidence matters, and how strong quality systems reduce pharmaceutical risk.
  • Blog, Quality Management System
Pharmazeutische Produktionsanlage mit GMP-Compliance, Datenintegrität, Kontaminationskontrolle und Qualitätsrisikomanagement in einer modernen Herstellungsumgebung.

Harmonization in Pharmacovigilance in 2026: Global Regulations, ICSR Reporting and ICH Standard

Drug safety requirements vary across regions, making consistent reporting a complex task for global teams. This article explains key regulatory expectations, ICH guidelines, ICSR reporting, MedDRA terminology, and practical considerations for maintaining compliant safety reporting worldwide.
  • Blog, Quality Management System
Digitales globales Netzwerk zur Darstellung von Arzneimittelsicherheitsmeldungen, ICSR-Berichterstattung und regulatorischer Koordination zwischen mehreren Ländern.

Scope of Pharmacovigilance in 2026: Drug Safety Roles Skills and Career Growth

Explore how drug safety teams manage ICSRs, signals, risks, inspections, and regulatory responsibilities. This article also explains key pharmacovigilance jobs, required skills, career progression, and the evidence companies need to maintain strong compliance.
  • Blog, Quality Management System
Ein Arzneimittelsicherheitsteam überprüft Nebenwirkungsmeldungen, Daten zur Signalerkennung und Dashboards zur Überwachung nach der Marktzulassung.

Pharmacovigilance System Master File in 2026: PSMF Requirements, EU GVP Module II, QPPV, and Inspection Readiness

Explore PSMF requirements, structure, maintenance, and inspection readiness under EU GVP Module II. This article explains QPPV responsibilities, annex control, computerised systems, audit evidence, and change management practices that help drug safety teams prepare for regulatory inspections.
  • Blog, Quality Management System
PSMF structure showing QPPV responsibilities, safety data systems, PSMF annexes, quality controls, audits, and inspection-ready documentation.

Risk Management Plan in Pharmacovigilance in 2026: EMA RMP and Safety Monitoring Guide

This guide explains how an EMA risk management plan supports safety specification, additional pharmacovigilance activities, and effective risk minimisation measures. It also shows how lifecycle updates help teams manage important identified risks and maintain a positive benefit-risk balance.
  • Blog, Quality Management System
Illustration of an EU risk management plan showing safety specification, important identified risks, lifecycle monitoring, and additional pharmacovigilance activities.